1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich

Repeated dose toxicity: inhalation

Administrative data

Endpoint:

sub-chronic toxicity: inhalation

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: The study is rated a "2" because appropriate testing methods were used; however, the study does not follow and accepted guideline or indicate compliance with GLP.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1981

Materials and methods

Principles of method if other than guideline:

As described previously, Pegg (1979) GM Research Reports

GLP compliance:

not specified

Limit test:

no

Test material

Test material information

Constituent 1

Reference substance name:

1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich

EC Number:

271-091-4

EC Name:

1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10-rich

Cas Number:

68515-49-1

Molecular formula:

C28 H46 O4

IUPAC Name:

1,2-Benzenedicarboxylic acid, di-C9-11-branched alkyl esters, C10 rich

Constituent 2

Reference substance name:

1,2-benzenedicarboxylic acid, di-C9,C10 and C11 branched alkyl ester, C10 Rich

IUPAC Name:

1,2-benzenedicarboxylic acid, di-C9,C10 and C11 branched alkyl ester, C10 Rich

Details on test material:

Unspecified DIDP; CAS No not provided

Test animals

Species:

rat

Strain:

Sprague-Dawley

Sex:

male

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Age at study initiation: adult
- Weight at study initiation: 125g
- Housing: individually in polycarbonate wire top cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7 days

Administration / exposure

Route of administration:

inhalation: aerosol

Type of inhalation exposure:

whole body

Vehicle:

other: unchanged (no vehicle)

Remarks on MMAD:

MMAD / GSD: MMAD = 0.98 um

Details on inhalation exposure:

GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
Data not available


TEST ATMOSPHERE
Repeated exposures to nonradioactive DIDP were conducted through whole body exposure in a 30L cylindrical glass jar. Animals were restrained in wire mesh cylinders and supported on a suspended screen floor. The chamber atmosphere was assayed for DIDP content on each exposure day. Cascade impactor samples for determination of aerosol particle size taken every other day during the exposure period.

Analytical verification of doses or concentrations:

not specified

Duration of treatment / exposure:

5 consecutive days, 2 days recovery and another 5 days exposure (10 total exposures)

Frequency of treatment:

6 hours/ day

Doses / concentrations

Remarks:

Doses / Concentrations:
500 mg/m3
Basis:
nominal conc.

No. of animals per sex per dose:

8 rats/dose
6 control rats

Control animals:

yes, concurrent no treatment

Details on study design:

Body weights of the animals were taken immediately before and after each 6 hour exposure period. After exposure, animals were returned to the vivarium. Control animals were exposed simultaneously in an identical chamber flushed with filtered room air. Rats were observed daily for body weight gain, appearance and gross behavior. At the end of the exposure regimen animals were held for observation for 3 weeks. Animals were sacrificed at the end of the observation period and tissue samples taken for histopathology.

Results and discussion

Results of examinations

Clinical signs:

no effects observed

Mortality:

no mortality observed

Body weight and weight changes:

effects observed, treatment-related

Food consumption and compound intake (if feeding study):

not specified

Food efficiency:

not specified

Water consumption and compound intake (if drinking water study):

not specified

Ophthalmological findings:

not specified

Haematological findings:

not specified

Clinical biochemistry findings:

not specified

Urinalysis findings:

not specified

Behaviour (functional findings):

not specified

Organ weight findings including organ / body weight ratios:

not specified

Gross pathological findings:

not specified

Histopathological findings: non-neoplastic:

effects observed, treatment-related

Histopathological findings: neoplastic:

not specified

Details on results:

The nominal chamber atmosphere concentration for the repeated exposure toxicity studies was 500 mg/m3. Daily, mean analytical concentrations ranged from 468 to 571 mg/m3. The mean analytical concentration for the ten exposure periods was 505 mg/m3. The mass median aerodynamic diameter of the DIDP aerosol was 0.98 um.

Animals exposed repeatedly to 500 mg/m3 DIDP exhibited no marked outward signs of toxicity during exposures. The rate of body weight gain was not different between control and exposed animals. Occasional changes in focal pulmonary histology were observed. Animals sacrificed 3 weeks following termination of exposure exhibited moderate increases in the weidth of alveolar septa with slight interstitial mixed inflammaotry reactions. Alveolar macrophages and type II pneumocytes were increased in number. Peribronchial lymphoid tissue appeared slightly more prominent in exposed animals. Liver, kidney and spleen from DIDP treated animals exhibited no obvious histologic alteration except for slight hepatic fatty metamorphosis.

Effect levels

Dose descriptor:

NOAEC

Effect level:

500 mg/m³ air

Sex:

male

Basis for effect level:

other: No systemic toxicity

Target system / organ toxicity

Critical effects observed:

not specified

Applicant's summary and conclusion

Conclusions:

The exposure regimen did not result in lethality when animals were observed for up to 3 weeks following treatment. Pulmonary irritation, however was apparent.

Executive summary:

In a 2-week study (General Motors Research Laboratories, 1981) designed to evaluate the fate of DIDP (see Section 5.1), toxicity was also assessed. DIDP was administered to 8 male rats (6 for control) by inhalation (aerosol) at analytical concentration of 505±7 mg/m³(MMAD: 0.98 μm) 6 hours a day, 5 times per week. Rats were observed daily for body weight gain, appearance and gross behavior. Animals were sacrificed at the end of the observation period (3 weeks) and tissue samples taken for histopathology. There were no marked outward signs of toxicity during exposure. The rate of body weight gain was not different between control and exposed animals. Effects in the lungs were: moderate increase in the width of alveolar septa with slight interstitial mixed inflammatory reactions, alveolar macrophages and type II pneumocytes were increased in number, peribronchial lymphoid tissue appeared slightly more prominent. In liver, spleen and kidneys, no obvious histologic alterations were noted except for a slight hepatic fatty metamorphosis. No systemic toxicity, but local irritant effects were observed at the concentration tested, thus a NOAEL of 0.5 mg/l (500 mg/m³) can be assumed.